LifeVantage Q1 revenue misses analyst estimates due to a decrease in active accounts
LFVN•LifeVantage’s fiscal Q1 revenue fell 22% year over year to $37.12 million, below the $40.49 million analyst estimate, as active accounts decreased. Adjusted EPS fell to $0.05 from $0.18 a year earlier.
1. Revenue and earnings
LifeVantage reported fiscal Q1 revenue of $37.12 million, down 22% year over year and below the $40.49 million estimate from three analysts. Adjusted EPS fell to $0.05 from $0.18 a year earlier, and the company recorded a net loss of $196,000.
2. Factors behind the decline
The company said lower revenue primarily reflected a decrease in active accounts, which it linked to impacts from the broader macro environment, as well as reduced sales of its MindBody GLP-1 System. Sales of the LoveBiome product line, acquired in October 2025, partially offset the declines.
3. Company outlook
LifeVantage did not provide specific financial guidance for upcoming quarters or the full year in its press release.
